PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

NCT00928408 · clinicaltrials.gov ↗

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperparathyroidism, Primary

Interventions

DRUG: Cinacalcet

Sponsor

Amgen